Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -9.67 | -9.95 | -9.42 | 48.19% | CHEMBL95104 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -10.14 | -9.32 | N/A | 54.05% | CHEMBL4076408 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -10.28 | -10.11 | -9.97 | 52.74% | CHEMBL209324 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.28 | -9.91 | N/A | 49.03% | CHEMBL600210 |
AA1R_HUMAN | adenosine A1 receptor | -9.36 | -9.27 | -7.94 | 39.13% | CHEMBL1760893 |
AA2AR_HUMAN | adenosine A2a receptor | -9.41 | -8.82 | -10.08 | 41.92% | CHEMBL486282 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -10.73 | -10.50 | -8.15 | 49.67% | CHEMBL3922423 |
ACE_HUMAN | angiotensin I converting enzyme | -9.29 | -9.50 | -8.09 | 41.18% | CHEMBL514138 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.29 | N/A | N/A | 22.91% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -7.09 | -8.81 | -7.67 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -10.09 | -4.14 | N/A | 43.95% | CHEMBL270580 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -9.71 | -7.34 | N/A | 44.71% | CHEMBL4082397 |
ADRB2_HUMAN | adrenoceptor beta 2 | -10.59 | -10.97 | -10.99 | 60.27% | CHEMBL1490889 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -9.34 | -9.19 | -8.88 | 37.66% | CHEMBL74144 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.82 | -9.34 | -10.31 | 42.42% | CHEMBL240719 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.40 | -9.20 | -9.81 | 32.08% | CHEMBL1828920 |
AOFA_HUMAN | monoamine oxidase A | -10.68 | -10.64 | -11.03 | 47.97% | CHEMBL3319257 |
AOFB_HUMAN | monoamine oxidase B | -11.08 | -10.30 | -10.74 | 47.97% | CHEMBL3319257 |
BACE1_HUMAN | beta-secretase 1 | -7.76 | -8.52 | -9.20 | 42.08% | CHEMBL1097346 |
CAH2_HUMAN | carbonic anhydrase 2 | -8.38 | -7.87 | -8.14 | 64.12% | CHEMBL295343 |
CASP1_HUMAN | caspase 1 | -7.00 | -7.79 | -6.92 | 54.84% | CHEMBL3133256 |
CDK5_HUMAN | cyclin dependent kinase 5 | -8.25 | -9.10 | -8.25 | 42.76% | CHEMBL1967612 |
CHLE_HUMAN | butyrylcholinesterase | -9.47 | -9.42 | -9.09 | 44.81% | CHEMBL4105611 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.14 | -9.99 | -10.12 | 89.47% | CHEMBL246302 |
CNR2_HUMAN | cannabinoid receptor 2 | -10.61 | -10.24 | N/A | 86.72% | CHEMBL253462 |
COLI_HUMAN | proopiomelanocortin | -9.51 | -8.65 | -8.64 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.98 | -6.47 | -6.15 | 31.17% | CHEMBL3818719 |
CRP_HUMAN | C-reactive protein | -6.46 | -6.68 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -6.03 | N/A | N/A | 40.70% | CHEMBL386072 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -9.23 | -7.20 | -7.88 | 40.00% | CHEMBL3627862 |
DRD2_HUMAN | dopamine receptor D2 | -9.26 | N/A | N/A | 54.39% | CHEMBL238917 |
DRD3_HUMAN | dopamine receptor D3 | -10.26 | N/A | N/A | 54.82% | CHEMBL238915 |
DRD4_HUMAN | dopamine receptor D4 | -9.96 | -10.17 | N/A | 49.70% | CHEMBL106917 |
EDN1_HUMAN | endothelin 1 | -8.77 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -8.84 | -8.82 | -8.42 | 55.56% | CHEMBL204185 |
FABP5_HUMAN | fatty acid binding protein 5 | -9.19 | -6.68 | -6.31 | 33.86% | CHEMBL3941588 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -9.26 | N/A | N/A | 40.72% | CHEMBL12131 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.49 | -9.41 | -9.45 | 35.06% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.51 | N/A | N/A | 35.06% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -9.06 | -7.11 | -6.62 | 43.48% | CHEMBL2338560 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -8.58 | -7.82 | -9.73 | 36.31% | CHEMBL3650206 |
HRH1_HUMAN | histamine receptor H1 | -8.70 | N/A | N/A | 47.98% | CHEMBL2207654 |
HYES_HUMAN | epoxide hydrolase 2 | -9.75 | -9.96 | -9.10 | 62.68% | CHEMBL2313192 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.34 | N/A | N/A | 50.00% | CHEMBL230055 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.97 | -9.04 | N/A | 46.28% | CHEMBL3612980 |
MIF_HUMAN | macrophage migration inhibitory factor | -7.47 | -7.17 | -6.46 | 28.79% | CHEMBL554271 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -8.58 | -8.01 | -9.12 | 48.53% | CHEMBL291338 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.81 | -8.49 | -8.48 | 35.20% | CHEMBL1336 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.64 | -9.60 | -9.51 | 43.90% | CHEMBL3594042 |
NEP_HUMAN | membrane metalloendopeptidase | -8.71 | -8.82 | -9.82 | 30.77% | CHEMBL467602 |
NK1R_HUMAN | tachykinin receptor 1 | -9.17 | -8.68 | -8.87 | 47.98% | CHEMBL321098 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -9.69 | -9.02 | -8.70 | 39.38% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -10.60 | -10.30 | -9.82 | 30.86% | CHEMBL444384 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -9.73 | -8.78 | -8.70 | 40.41% | CHEMBL159739 |
NOS1_HUMAN | nitric oxide synthase 1 | -9.66 | -9.12 | -9.88 | 36.14% | CHEMBL491922 |
NOS2_HUMAN | nitric oxide synthase 2 | -9.37 | -9.33 | -8.63 | 40.46% | CHEMBL512501 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.39 | -9.92 | -8.61 | 44.64% | CHEMBL1996795 |
OPRD_HUMAN | opioid receptor delta 1 | -8.23 | -8.01 | -7.58 | 44.29% | CHEMBL571324 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.71 | -9.47 | -9.22 | 46.85% | CHEMBL1710945 |
OPRM_MOUSE | Mu-type opioid receptor | -9.08 | -8.78 | N/A | 37.58% | CHEMBL283552 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -8.72 | -8.55 | -8.80 | 51.06% | CHEMBL3942616 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.60 | -5.99 | -6.67 | 36.98% | CHEMBL3674806 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.98 | -8.92 | -9.26 | 40.95% | CHEMBL2419489 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -9.83 | N/A | N/A | 41.22% | CHEMBL2049115 |
PDE4B_HUMAN | phosphodiesterase 4B | -8.92 | -9.49 | -9.28 | 44.91% | CHEMBL576479 |
PDE5A_HUMAN | phosphodiesterase 5A | -9.09 | -9.87 | -9.03 | 45.95% | CHEMBL544540 |
PERM_HUMAN | myeloperoxidase | -8.49 | -8.61 | -8.66 | 34.42% | CHEMBL86 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -9.65 | -8.99 | -9.58 | 39.13% | CHEMBL8916 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -5.01 | -6.87 | -8.25 | 48.53% | CHEMBL291338 |
PPAP_HUMAN | acid phosphatase 3 | -8.01 | N/A | N/A | 22.42% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -9.16 | -9.66 | -8.98 | 51.72% | CHEMBL496534 |
PRGR_HUMAN | progesterone receptor | -6.62 | -6.36 | -8.87 | 43.21% | CHEMBL591072 |
PTGES_HUMAN | prostaglandin E synthase | -8.63 | N/A | N/A | 47.53% | CHEMBL3092270 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.82 | -9.29 | -9.56 | 52.74% | CHEMBL209324 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -8.57 | N/A | N/A | 41.36% | CHEMBL3657813 |
TLR4_HUMAN | toll like receptor 4 | -9.25 | -9.93 | -8.74 | 29.03% | CHEMBL1223752 |
TNFA_HUMAN | tumor necrosis factor | -8.17 | N/A | N/A | 62.00% | CHEMBL1607187 |
TRBM_HUMAN | thrombomodulin | -10.13 | -7.68 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.82 | -7.57 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -9.79 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.95 | N/A | N/A | 44.00% | CHEMBL214880 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.49 | -9.42 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -8.49 | -8.07 | N/A | 42.86% | CHEMBL3692262 |
TRXR1_HUMAN | thioredoxin reductase 1 | -9.01 | -8.28 | -7.26 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.70 | N/A | N/A | 48.48% | CHEMBL297835 |